Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 4Stomatitis 3Neoplasm Metastasis 2Head and Neck Neoplasms 2Cancer Pain 2Thromboembolism 1Successful Conversion Rate of Operation 1Sarcoma 1Respiratory Insufficiency 1Prostatic Neoplasms 1Pneumonia 1Pancreatic Neoplasms 1Pain 1Myocardial Infarction 1Multiple Myeloma 1Mucositis 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Kidney Diseases 1Hematologic Neoplasms 1Arrhythmias, Cardiac 1Angina, Unstable 1Adenocarcinoma 1Acute Coronary Syndrome 1

Interventions

Gemcitabine 679130-nm albumin-bound paclitaxel 198Fluorouracil 186Oxaliplatin 175Albumin-Bound Paclitaxel 151Capecitabine 137Leucovorin 131Irinotecan 113Radiotherapy 95Taxes 83pembrolizumab 80Cisplatin 72Erlotinib Hydrochloride 69Radiosurgery 67Nivolumab 56Bevacizumab 54Drug Therapy 52Cyclophosphamide 49Magnetic Resonance Spectroscopy 46folfirinox 42Docetaxel 41Cetuximab 40Specimen Handling 37irinotecan sucrosofate 36S 1 (combination) 36Biopsy 31Radiation 29Paclitaxel 29Ipilimumab 27durvalumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pancreatic Neoplasms × Sodium Bicarbonate × Clear all
NCT01198821 2017-02-23

Gem-TABS in Unresectable Pancreatic Carcinoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
8 enrolled
Gastrointestinal

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡